Advancing Drug Discovery with the Precision and Power of AI
Rakovina Therapeutics is an AI-driven drug discovery company focused on DNA Damage Response (DDR) therapies for cancer. We combine advanced AI platforms with world-class research to discover and develop next-generation medicines that can transform lives.
THE RAKOVINA DIFFERENCE
Finding the signal that matters
AI-Powered Discovery
Multiple proprietary and partner AI platforms explore vast chemical space to identify high-potential drug candidates.
Focused Oncology Strategy
Targeting DNA Damage Response (DDR) pathways while developing therapies designed to cross the blood-brain barrier.
Wet-Lab Validation
Candidates validated in-house through established laboratory infrastructure at the University of British Columbia and the Vancouver Prostate Centre.
100% Candidate Ownership
Rakovina owns the rights to all drug candidates generated through its discovery programs.
LATEST NEWS



